Skip to Main Content

Author Details

Shawn Anderson
University of British Columbia
2009
19
16
PMIDPaper TitleJournal TitlePublished Year
33441310Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.Cancer Res2021
30636931Markers of MEK inhibitor resistance in low-grade serous ovarian cancer: EGFR is a potential therapeutic target.Cancer Cell Int2019
28330676Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.Eur Urol2018
28768687HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology.Genome Res2017
28205537Her2 alterations in muscle-invasive bladder cancer: Patient selection beyond protein expression for targeted therapy.Sci Rep2017
27822414Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.Am J Cancer Res2016
25712683Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.Clin Cancer Res2015
26041878Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.Oncotarget2015
24318647Suppression of lipopolysaccharide-stimulated cytokine/chemokine production in skin cells by sandalwood oils and purified α-santalol and β-santalol.Phytother Res2014
25241927Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.Bioorg Med Chem Lett2014
25170619CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells.PLoS One2014
25155515Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.Genome Biol2014
24356420High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.Cancer Res2014
23500642Hiding in plain view: genetic profiling reveals decades old cross contamination of bladder cancer cell line KU7 with HeLa.J Urol2013
23436932Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3.J Immunol2013
22294438Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.J Pathol2012
22553170From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.J Pathol2012
22252602Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.Mol Cancer Ther2012
19409931Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract.Antiviral Res2009
  • 1 - 19 of 19

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 6
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Kien Pham
Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 1
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 14
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 0
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 3
Jonathan Chou
University of California san francisco
Career Start Year 2005
Number of shared co-authors 18
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 1
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 3
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 3
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Habib Hamidi
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 6
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 2
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 13
Franklin W Huang
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 19
Andrey Loboda
Merck & Co., Inc.
Career Start Year 1998
Number of shared co-authors 1
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
Robert Kim
University of California
Career Start Year 1996
Number of shared co-authors 9
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 23
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 3
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 4
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 8
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 4
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 15
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 14
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 14

Collaborators

Colin C Collins
University of British Columbia
Co-authored papers 12
Robert H Bell
University of British Columbia
Co-authored papers 10
Stanislav V Volik
University of British Columbia
Co-authored papers 9
Anne Haegert
University of British Columbia
Co-authored papers 9
Martin E Gleave
University of British Columbia
Co-authored papers 8
Yuzhuo Wang
University of British Columbia
Co-authored papers 7
Alexander W Wyatt
University of British Columbia
Co-authored papers 7
Sonal Brahmbhatt
University of British Columbia
Co-authored papers 7
Fan Mo
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 6
Ladan Fazli
University of British Columbia
Co-authored papers 6
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 5
Brian McConeghy
University of British Columbia
Co-authored papers 5
Anna Lapuk
Contextual Genomics Inc.
Co-authored papers 4
Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 4
Suleyman Cenk Sahinalp
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 4
Robert Shukin
University of British Columbia
Co-authored papers 4
Raunak Shrestha
University of California San Francisco
Co-authored papers 3
Estelle Li
University of British Columbia
Co-authored papers 3
Andrew McPherson
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Elai Davicioni
Veracyte Inc.
Co-authored papers 3
Christopher A Maher
Washington University in St Louis
Co-authored papers 3
Dong Lin
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 3
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 3
Mark A Rubin
University of Bern
Co-authored papers 3
Marco A Marra
University of British Columbia
Co-authored papers 3
Chunxiao Wu
Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers 3
Martin Hirst
University of British Columbia
Co-authored papers 2
Faraz Hach
University of British Columbia
Co-authored papers 2
Fereydoun Hormozdiari
University of California davis
Co-authored papers 2
Release 1.2